Related Experiment Videos
Ovulation induction for polycystic ovary syndrome
1Department of Reproductive Medicine, The General Infirmary, Leeds LS2 9NS, UK.
Human Fertility (Cambridge, England)
|February 15, 2002
Summary
Polycystic ovary syndrome (PCOS) is a leading cause of infertility. Current ovulation induction strategies for PCOS lack definitive evidence for optimal pregnancy success, necessitating careful monitoring due to risks like OHSS.
Area of Science:
- Reproductive Endocrinology
- Gynecology
- Infertility Research
Background:
- Polycystic ovary syndrome (PCOS) is the most frequent cause of anovulatory infertility.
- Factors like obesity and high luteinizing hormone (LH) levels negatively impact ovarian function and fertility in women with PCOS.
- Established ovulation induction methods include weight loss, anti-estrogens (clomiphene citrate), gonadotropins, and ovarian surgery.
Purpose of the Study:
- To review and compare the efficacy of various ovulation induction strategies for achieving ongoing pregnancy in women with PCOS.
- To highlight the need for adequately powered randomized studies to determine the best therapeutic approach.
- To discuss the risks associated with ovulation induction, such as ovarian hyperstimulation syndrome (OHSS), and the importance of monitoring.
Main Methods:
- Review of existing literature on ovulation induction in PCOS.
- Analysis of factors influencing ovarian function and fertility in PCOS.
- Discussion of therapeutic options including lifestyle changes, pharmacotherapy, and surgical interventions.
- Emphasis on the importance of careful monitoring with ultrasound scans due to OHSS risk.
Main Results:
- No adequately powered randomized studies currently exist to definitively rank the effectiveness of different ovulation induction therapies for PCOS.
- Women with PCOS are susceptible to OHSS, requiring meticulous monitoring during ovulation induction.
- Insulin-sensitizing agents like metformin show promise in improving the biochemical profile and reproductive outcomes in PCOS.
Conclusions:
- The optimal ovulation induction strategy for PCOS remains undetermined due to a lack of high-quality comparative data.
- Careful patient selection and monitoring are crucial to mitigate risks like OHSS during fertility treatments for PCOS.
- Metformin and other insulin-sensitizing agents represent a valuable therapeutic avenue for managing PCOS-related infertility.